Skip to main content

Table 1 Demographics

From: Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy

 

ST cases

Individual Controls

p value

Age

61.9 ± 5.7

61.8 ± 4.3

N/S

Sex (% Male)

86

86

N/S

Smokers (%)

42.9

35.7

N/S

Diabetes (%)

14.3

14.3

N/S

Emergency cases (%)

14.3

14.3

N/S

Elective cases (%)

14.3

33.3

N/S

ACS cases (%)

71.4

52.4

N/S

Stent length (mm)

26.7 ± 11.3

27.9 ± 6.3

N/S

Minimum stent diameter (mm)

2.8 ± 0.3

2.9 ± 0.3

N/S

Aspirin dose (mg)

140 ± 21.0

140 ± 13.4

N/S

Clopidogrel dose (mg)

86 ± 21

75

N/S

Duration of clopidogrel (days)

161 ± 163

77 ± 28

N/S

Time from latest event/intervention (days)

145 ± 84

76 ± 28

N/S

Statin (% total/% Atorvastatin)

100/14

100/7

N/S

  1. Summary of demographics in the seven cases and 14 controls. There are no significant differences between the groups.